Interpace Biosciences Inc (NASDAQ:IDXG)
| 3.48 Delayed Data As of Oct 30 |  +0.03 / +0.87%Today’s Change | 2.57 Today|||52-Week Range 11.00 | -30.40% Year-to-Date |
Latest IDXG News | Press Releases
No recent news for Interpace Biosciences Inc.
Today’s Trading
| Previous close | 3.45 |
| Today’s open | 3.51 |
| Day’s range | 3.42 - 3.51 |
| Volume | 401 |
| Average volume (3 months) | 922,949 |
| Market cap | $13.7M |
Data as of 3:42pm ET, 10/30/2020
Growth & Valuation
| Earnings growth (last year) | -1,574.59% |
| Earnings growth (this year) | +25.90% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +9.97% |
| P/E ratio | NM |
| Price/Sales | 0.08 |
| Price/Book | 1.02 |
Competitors
Data as of 3:59pm ET, 10/30/2020
Financials
| Next reporting date | November 11, 2020 |
| EPS forecast (this quarter) | -$1.30 |
| Annual revenue (last year) | $24.1M |
| Annual profit (last year) | -$26.7M |
| Net profit margin | -110.63% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Parsippany, New Jersey |
Forecasts
